Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Witzmann

Showing results (21-30 of 168) with videos related to

Pageof 17
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Two-dimensional gels for toxicological drug discovery applicationsFrank A Witzmann, Matthew R Richardson
Zentralblatt Fur Neurochirurgie|January 1, 1994
[Why still use myelography in neurosurgery?]A Huber, A Witzmann, J Fischer
International Journal of Biomedical Nanoscience and Nanotechnology|November 15, 2013
Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gapsIngrid L Bergin, Frank A Witzmann
Electroencephalography and Clinical Neurophysiology|July 1, 1986
Somatosensory evoked potentials (SSEPs) in various groups of cerebro-vascular ischaemic diseaseF Reisecker, A Witzmann, E Deisenhammer
International Review of Neurobiology|October 16, 2004
Proteomics and alcoholismFrank A Witzmann, Wendy N Strother
Neurochirurgia|November 1, 1981
[Glioblastoma multiforme developing after a gunshot injury of the brain (author's transl)]A Witzmann, K Jellinger, R Weiss
Surgical Neurology|December 26, 2001
Ocular manifestations of sphenoid mucoceles: clinical features and neurosurgical management of three cases and review of the literatureN Hejazi, A Witzmann, W Hassler
The Pharmacogenomics Journal|May 15, 2003
Pharmacoproteomics in drug developmentFrank A Witzmann, Raymond A Grant
Neuroradiology|January 1, 1991
Free sequestered disc herniation at the S2 level misdiagnosed as neuromaA Witzmann, B Hammer, J Fischer
Analytical Biochemistry|September 23, 1997
Locating Western blotted and immunostained proteins within complex two-dimensional patternsC D Fultz, F A Witzmann
Pageof 17

Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Two-dimensional gels for toxicological drug discovery applicationsFrank A Witzmann, Matthew R Richardson
Zentralblatt Fur Neurochirurgie|January 1, 1994
[Why still use myelography in neurosurgery?]A Huber, A Witzmann, J Fischer
International Journal of Biomedical Nanoscience and Nanotechnology|November 15, 2013
Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gapsIngrid L Bergin, Frank A Witzmann
Electroencephalography and Clinical Neurophysiology|July 1, 1986
Somatosensory evoked potentials (SSEPs) in various groups of cerebro-vascular ischaemic diseaseF Reisecker, A Witzmann, E Deisenhammer
International Review of Neurobiology|October 16, 2004
Proteomics and alcoholismFrank A Witzmann, Wendy N Strother
Neurochirurgia|November 1, 1981
[Glioblastoma multiforme developing after a gunshot injury of the brain (author's transl)]A Witzmann, K Jellinger, R Weiss
Surgical Neurology|December 26, 2001
Ocular manifestations of sphenoid mucoceles: clinical features and neurosurgical management of three cases and review of the literatureN Hejazi, A Witzmann, W Hassler
The Pharmacogenomics Journal|May 15, 2003
Pharmacoproteomics in drug developmentFrank A Witzmann, Raymond A Grant
Neuroradiology|January 1, 1991
Free sequestered disc herniation at the S2 level misdiagnosed as neuromaA Witzmann, B Hammer, J Fischer
Analytical Biochemistry|September 23, 1997
Locating Western blotted and immunostained proteins within complex two-dimensional patternsC D Fultz, F A Witzmann
Pageof 17